| Listed site | cro | cro |
|---|
| Summary | Global pharmaceutical development organization offering integrated drug discovery, preclinical safety/toxicology, DMPK, bioanalytical, and clinical trial services across 28 sites with 2,200 employees and 200+ FDA inspections. | Global preclinical CRO specializing in kinase drug discovery, cell-based assays, in vivo pharmacology, and immuno-oncology with 1,000+ cell lines and hundreds of validated protein targets across US and EU facilities. |
|---|
| Services | - Medicinal Chemistry
- Computational & In-Silico Drug Discovery
- In Vitro ADME / DMPK
- In Vitro Pharmacology
- Preclinical In Vitro Studies
- Safety Pharmacology
- Genetic Toxicology
- DART (Reproductive & Developmental Toxicology)
- GLP Toxicology
- In Vivo PK / PD Studies
- In Vivo Efficacy Models
- Preclinical In Vivo Studies
- Phase I Clinical Trials
- Phase II Clinical Trials
- Clinical Operations
- Bioanalysis
- LC-MS Bioanalysis (Small Molecule)
- Ligand-Binding Bioanalysis (Large Molecule)
- Immunogenicity Assays (ADA / NAb)
- Biomarker Assays
- Flow Cytometry Services
- Central Laboratory Services
- Pathology & Histology Services
- Genomics & Sequencing Services
- Biostatistics & Statistical Programming
- Data Management & eClinical
- Medical Writing
- Analytical Method Development & Validation
- ICH Stability Studies
- Discovery Research
- Target Identification & Validation
- High-Throughput Screening
- Specialized & Large-Animal Models
- Phase III Clinical Trials
- Clinical Trial Services
- Regulatory Affairs
- US FDA Regulatory Strategy
| - High-Throughput Screening
- In Vitro Pharmacology
- In Vitro ADME / DMPK
- Safety Pharmacology
- GLP Toxicology
- In Vivo PK / PD Studies
- In Vivo Efficacy Models
- Preclinical In Vivo Studies
- Preclinical In Vitro Studies
- Biomarker Assays
- Flow Cytometry Services
- Translational Research
- Discovery Research
- Specialized & Large-Animal Models
- Oncology Specialty Services
- Immunology & Inflammation Services
- Target Identification & Validation
- Genetic Toxicology
- Immunogenicity Assays (ADA / NAb)
|
|---|
| Modalities | - Small Molecule
- Biologics (Monoclonal Antibodies)
- Antibody-Drug Conjugate (ADC)
- Cell Therapy
- Gene Therapy
| - Small Molecule
- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Antibody-Drug Conjugate (ADC)
- Cell Therapy
|
|---|
| Indications | | - Oncology
- Immunology
- Infectious Disease
|
|---|
| Locations | - Headquarters
- Global Operations
| - Global Headquarters, Malvern, PA, USA
- Hershey, Hershey, PA, USA
- Freiburg, Freiburg, Freiburg, Germany
- Heidelberg, Heidelberg, Heidelberg, Germany
- Research Facility, Hershey, PA, USA
- Research Facility, Freiburg, Freiburg, Germany
- Research Facility, Heidelberg, Heidelberg, Germany
|
|---|
| Certifications | - FDA · Identifier: 200+ FDA Inspections
| - ISO · Identifier: ISO 9001:2015
|
|---|
| Reviews | Review summary appears after site-level review signal gate opens. | Review summary appears after site-level review signal gate opens. |
|---|